Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
<h4>Background</h4>Hepatitis C virus (HCV) infection is highly prevalent in renal transplant (RT) recipients. Currently, interferon-based (IFN-based) antiviral therapies are the standard approach to control HCV infection. In a post-transplantation setting, however, IFN-based therapies ap...
Saved in:
Main Authors: | Fang Wei, Junying Liu, Fen Liu, Huaidong Hu, Hong Ren, Peng Hu |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/5f797e27dbda45cfa5f7f70aad8dec00 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.
by: Xiwei Wang, et al.
Published: (2014) -
Urolithiasis in Renal Transplantation Patients: An Update of the Literature
by: Abdolreza Mohammadi, et al.
Published: (2021) -
Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
by: Aixin Song, et al.
Published: (2021) -
Blood Glucose and Renal Function Evaluation in Patients with Viral Hepatitis
by: Hsu WT, et al.
Published: (2021) -
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
by: Qian Chen, et al.
Published: (2021)